GlycoNex Incorporation (4168.TWO)
TWD 16.45
(2.17%)
TWD 16.45
(2.17%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 900 Thousand TWD | -99.6% |
| 2022 | 224.57 Million TWD | 24853.22% |
| 2021 | 900 Thousand TWD | 0.0% |
| 2020 | 900 Thousand TWD | 0.0% |
| 2019 | - TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.86 Million TWD | 315.11% |
| 2024 Q1 | 450 Thousand TWD | -50.0% |
| 2023 FY | 900 Thousand TWD | -99.6% |
| 2023 Q2 | 212.48 Million TWD | -3.66% |
| 2023 Q1 | 220.55 Million TWD | 0.0% |
| 2023 Q3 | 1.35 Million TWD | -99.36% |
| 2023 Q4 | 900 Thousand TWD | -33.33% |
| 2022 Q4 | - TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 99.777% |
| Sagittarius Life Science Corp | 13.32 Million TWD | 93.245% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 99.954% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -3.448% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | 74.944% |
| Bio Preventive Medicine Corp. | 113.44 Million TWD | 99.207% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | 57.427% |
| Level Biotechnology Inc. | 13.5 Million TWD | 93.334% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | 99.071% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 99.88% |
| VBI | - TWD | -Infinity% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | 99.65% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 99.719% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 99.683% |
| Visgeneer Inc. | 158.6 Million TWD | 99.433% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 99.876% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | 99.483% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | 83.428% |
| Neith Corporation | 3.54 Million TWD | 74.583% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | 23.143% |
| Enimmune corporation | 45.73 Million TWD | 98.032% |
| TaiRx, Inc. | 12.28 Million TWD | 92.675% |
| EirGenix Inc. | 465.16 Million TWD | 99.807% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | 98.454% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | 99.77% |
| Lin BioScience, Inc. | 42.87 Million TWD | 97.901% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | 93.126% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | 91.665% |
| Lukas Biomedical Inc. | 82.55 Million TWD | 98.91% |
| RBC Bioscience Corporation | 487.36 Million TWD | 99.815% |
| BiOptic Inc. | 93.19 Million TWD | 99.034% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | 34.924% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -67.286% |
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | 93.739% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 99.868% |
| NaviFUS Corp. | 32.69 Million TWD | 97.247% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 99.784% |
| Sinew Pharma Inc. | 6.46 Million TWD | 86.077% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | 96.682% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | 99.541% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | 92.863% |
| AP Biosciences Inc | 82.07 Million TWD | 98.903% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 99.969% |
| 3D Global Biotech Inc. | 10.37 Million TWD | 91.329% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | 99.377% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 99.937% |
| Oneness Biotech Co., Ltd. | 397.95 Million TWD | 99.774% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | 79.329% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | 88.709% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | 84.741% |
| TCI GENE Inc. | 6.79 Million TWD | 86.755% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | 89.18% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | 90.626% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | 99.665% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | 91.575% |
| PharmaEngine, Inc. | 14.8 Million TWD | 93.923% |
| Savior Lifetec Corporation | 270.37 Million TWD | 99.667% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | 98.795% |
| OBI Pharma, Inc. | 501.05 Million TWD | 99.82% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | 97.356% |
| Acepodia, Inc. | 273.81 Million TWD | 99.671% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | 95.601% |